An Introduction to COVID-19
On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic. The impact on the medical community has been huge, not only on the front line of medical care but also for those navigating patient treatment during this unprecedented situation.
The touchINFECTIOUS DISEASES expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Paul Heath: Novavax Phase 3 Program of Clinical trials evaluating NVX-CoV2373 across the US, South Africa and UK [Part 2]
It was a great pleasure to meet with Prof. Paul Heath (St George’s, University of London, London, UK) to discuss the findings from the Novavax program of clinical trials evaluating the safety and efficacy of NVX-CoV2373 across the US, South Africa and the UK. Please find Part 1 of this interview available here. To access […]
Paul Heath: Phase 3 trial of Novavax Investigational COVID-19 vaccine [Part 1]
It was a great pleasure to meet with Prof. Paul Heath (St George’s, University of London, London, UK) to discuss the findings from the Phase III Novavax clinical trial that is investigating the safety and efficacy of NVX-CoV2373, a vaccine candidate for COVID-19. Please find Part 2 of this interview available here. To access more […]
Jeffrey Strich: Phase 2 Trial Results Investigating Fostamatinib for the treatment of COVID-19
It was a great pleasure to meet with Jeffrey Strich (National Institutes of Health Clinical Center, Bethesda, MD, USA) to discuss the findings from a recent phase 2 study investigating fostamatinib for the treatment of hospitalized adults with COVID-19. Useful Resources: Published data available here: Fostamatinib for the treatment of hospitalized adults with COVID-19 A […]
Evangelos Giamarellos-Bourboulis: Phase 3 SAVE-MORE Study Results Investigating Anakinra in the Treatment of Severe COVID-19
It was a great pleasure to meet with Prof. Evangelos Giamarellos-Bourboulis (Attikon University Hospital, Athens, Greece) to discuss phase 3 SAVE-MORE study assessing the effect of anakinra for the treatment of patients with COVID-19 pneumonia. Useful Resources: Publication available to access here: https://www.nature.com/articles/s41591-021-01499-z Questions: Could you give us a brief overview of the role of […]
Rifaat Safadi, EASL ILC 2021: Impact of Liver Disease on SARS-CoV-2 Vaccine Response
It was a pleasure to speak with Prof. Rifaat Safadi (Hadassah University Hospital, Ein Kerem, Jerusalem) about the impact of advanced chronic liver disease on the efficacy of the Pfizer and Moderna mRNA SARS-CoV-2 vaccines. His abstract entitled ‘Elderly with advanced liver fibrosis had lower response to Pfizer’s SARS-CoV-2 vaccine response’ was presented at EASL […]
Timothy Hinks, ECCMID 2021: ATOMIC2 Study Results
touchINFECTIOUSDISEASES were pleased to meet with Timothy Hinks (Nuffield Department of Medicine, University of Oxford, Oxford, UK) to discuss the results of the ATOMIC2 study results, investigating azithromycin in the treatment of COVID-19. The abstract entitled: ‘A randomised clinical trial of azithromycin versus standard care in ambulatory COVID-19: the ATOMIC2 trial’ was presented at the […]
Beatriz Mateos, EASL ILC 2021: Tenofovir in Hepatitis B Patients with COVID-19
It was lovely to speak with Dr Beatriz Mateos (Universidad de Alcalá, Madrid, Spain) about the findings from her research into the impact of tenofovir on the severity of COVID-19 infection in those with chronic hepatitis B. Her presentation entitled ‘Tenofovir reduces the severity of COVID-19 infection in chronic hepatitis B patients’ was given at […]
Alba Grifoni, HIVR4P 2021: T Cell Responses of SARS-CoV-2 Epitopes
We were delighted to have the opportunity to speak with Dr Alba Grifoni ( La Jolla Institute for Immunology, La Jolla, CA, USA) to discuss T Cell responses of SARS-CoV-2 epitopes in COVID-19 cases. Her abstract entitled: ‘B & T cell interactions: New studies on COVID-19’ (SY08.05) was presented at the HIVR4P Virtual Conference 2021, […]
Carlos Chaccour, ISNTD d3 2021: Ivermectin for COVID-19
It was a delight to be able to speak with Dr Carlos Chaccour (University of Barcelona, Barcelona, Spain) about the controversy currently surrounding the use of ivermectin for the treatment of COVID-19. His presentation entitled Ivermectin and COVID: what’s going on? was presented at the ISNTD d3 2021 Virtual Congress, 24-25 February. Questions: Could you […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!